Making Possibility Visible. Original editorial painting of an imagined optical prism revealing a spectrum, a symbol of what the right research capability can help us see.
Choose the expertise and agreement that fit the problem before committing your money or your invention
By Arbab Naseebullah Kasi, Chief Executive Officer - CEO, Feel Worldwide Foundation Inc.
A prototype can work well enough to excite its creator and still leave the most important question unanswered.
Will the material survive repeated heating? Can a measurement be reproduced outside the inventor's workshop? Does a promising process still work when the batch becomes larger? Before a customer relies on the answer, someone must investigate it carefully.
A university or federal laboratory may have an instrument, a specialist or a body of knowledge that a young company could not reasonably build for itself. Working with that institution can make a difficult question answerable. It can also introduce costs, approval requirements and ownership terms that the company has never encountered.
The useful ambition is therefore specific: find a partner who can help resolve a consequential uncertainty, then agree on how the result can be used. An impressive institutional name is not enough. The relationship must fit the science, the business and the public purpose of the institution.
Begin with the missing capability
Imagine a small manufacturer developing a reusable insulated container. Early samples perform well, but the team does not understand why performance varies after repeated washing. This is an illustrative situation, not a report of a real company or Foundation project.
The manufacturer might need a standard materials test. It might need a researcher to investigate an unfamiliar degradation mechanism. Or it might discover that a university already owns a relevant coating technology that could be licensed. These are different needs, even though each conversation begins with the same product.
Write the first inquiry around what is missing. Describe the intended use, the observations already made, the uncertain point and the decision an answer would support. Ask whether the institution has the relevant expertise and whether the work fits its mission and available capacity.
Keep that first description nonconfidential. A useful introduction does not need the complete formula, source code or unpublished design. If sensitive technical detail becomes necessary, involve the institution's authorized office in arranging appropriate confidentiality terms before sharing it.
A test is not always a research partnership
If the question can be answered through an established procedure with a defined output, a technical service or facility arrangement may be the sensible starting point. Agree on sample preparation, test conditions, the form of the results, responsibility for interpretation and whether the method is suitable for the intended decision.
The University of Massachusetts Amherst makes a practical distinction in its Sponsored Research Agreement Guide. Its research services agreement is for short test or service projects outside the core facilities where research and new intellectual property are not anticipated. Its sponsored research agreement serves a research project with an industry sponsor. Those are that university's categories, not interchangeable national contract labels.
A service can produce valuable evidence without becoming a joint discovery effort. Conversely, calling work a service does not make a genuine research uncertainty disappear. If the team must invent a method, explore an unknown mechanism or change the scope as discoveries emerge, discuss the appropriate research arrangement rather than forcing the project into a convenient purchase order.
Federal laboratories also offer different mechanisms. At the National Energy Technology Laboratory, or NETL, a Contributed Funds Agreement allows an outside party to pay for work performed by the laboratory, with full reimbursement required. NETL says new inventions it makes under that arrangement belong to the Department of Energy. Paying the bill is therefore not the same as buying ownership of every result.
Understand what a CRADA actually provides
A Cooperative Research and Development Agreement, usually shortened to CRADA, supports collaborative work with a federal laboratory. It should not be mistaken for a startup grant, a government purchase order or an automatic commercial license.
The National Institute of Standards and Technology's CRADA guidance explains that projects must fit NIST's mission and receive its approval. NIST may contribute personnel, equipment, facilities and other resources, but cannot transfer funds to the collaborator through the CRADA. The collaborator may contribute money or other resources. Each party may take title to intellectual property created by its employees, and the collaborator receives a first option to license NIST or jointly developed inventions on reasonable commercial terms.
That option matters. It provides a route to a later agreement, not permission to assume that all resulting technology is already yours to sell.
NETL similarly expects a substantive collaboration in which the outside participant actively contributes to the research. Merely handing over samples while the laboratory performs essentially all the research does not meet its description of a CRADA. The proposed division of work should be credible before either side starts negotiating the document.
Read the ownership terms before the exciting experiment
Separate what each party brings from what the project may create. Existing patents, software, designs and other assets are often described as background intellectual property. New inventions arising from the project need their own treatment. Data, physical samples, reports and software may involve different rights again.
NETL's Short Form CRADA model dated February 25, 2026 makes a particularly useful distinction. Article XV allows use of identified background intellectual property for the agreed research, but does not grant a commercial license to it. Separate licensing is needed. Article VI also preserves government rights in subject inventions and addresses joint ownership.
A business could otherwise finish a successful project and discover that an essential earlier technology remains outside its commercial permissions. Ask what additional rights would be needed to manufacture, sell, support or sublicense the intended product. Check whether those rights are actually available and who has authority to grant them.
University sponsorship also needs careful reading. The University of Michigan's technology commercialization FAQ says that many sponsored research agreements offer an industry partner a limited-term option to negotiate a license. It also states that intellectual property made under sponsored research and material transfer agreements belongs to the university unless otherwise agreed in writing. A founder should not assume that funding a professor's work transfers the university's rights.
Have appropriate legal advisers review the intended commercial use alongside the contract. A patent license is not a blanket assurance that a product avoids everyone else's patents, meets safety requirements or has regulatory approval. Those questions require separate work.
Budget beyond the laboratory invoice
The full cost includes more than instrument time. A company may need to prepare samples, assign engineers, travel, repeat a failed measurement, obtain insurance, negotiate agreements and pay for later patent or licensing work. Money spent internally is still money the project consumes.
University budgets can include facilities and administrative costs as well as project-specific expenses. The University of Michigan's current F&A guidance explains the institutional costs that support research and publishes different rates for different activities and locations. Ask for the applicable rate, calculation base and exclusions rather than applying a headline percentage to every budget item.
Illustrative budget, not a quote: Suppose a company sets aside $30,000 for external research, $12,000 for its own engineering time and $8,000 for samples, shipping and specialist advice. Its planned commitment is $50,000. If a further $5,000 is reserved for defined contingencies, the amount to finance is $55,000. These invented figures are arithmetic for planning, not typical laboratory prices or an estimate of what any institution will charge.
The same discipline applies when no invoice changes hands. Oak Ridge National Laboratory's Manufacturing Demonstration Facility Technical Collaboration Program describes a model in which ORNL and the company make equal contributions without exchanging money. That is a feature of this program, not a promise that national laboratory research is free. The company's people, materials and time still have an opportunity cost.
Ask when cash must be available, which contributions qualify, what happens if the work changes and what costs remain if the project stops. A technically attractive proposal can be financially unsuitable at the wrong stage of a business.
Put the calendar beside the budget
A researcher may be enthusiastic while the institution still needs time for contracting, safety review, equipment scheduling and access approval. Enthusiasm is not a confirmed start date.
ORNL's Technical Collaboration Program currently describes project development and agreement work as taking three to four months, followed by execution lasting six months to two years. It says agreement processing for international companies takes about twice as long because of additional Department of Energy reviews. These are program descriptions checked on November 10, 2026, not guaranteed deadlines for a particular applicant.
Build a plan that distinguishes the date of a scientific conversation from the date authorized work can begin. Identify dependencies such as sample readiness, laboratory availability and company staffing. Ask what happens if the principal researcher becomes unavailable or a critical instrument needs repair.
Do not promise a customer's delivery date around an unsigned agreement. If the business needs a quick, standardized answer, the right commercial testing provider may fit better than a longer collaborative study.
Protect information without assuming permanent secrecy
Research institutions have responsibilities beyond one sponsor's commercial timetable. Publication rights, student progress and dissemination of knowledge may be central to their mission.
The University of Michigan's Openness in Research policy rejects unreasonable restrictions on publishing research results. Its standard restrictions can allow a publication delay of up to 180 days for specified review purposes, including protection of sponsor-provided confidential information and intellectual property. Longer delays and sponsor approval requirements need additional review. This is Michigan's policy, not a general entitlement to delay any university publication for six months.
Discuss the difference between confidential information you provide and results the researchers generate. Agree on how information must be marked, who can receive it, the review process and the applicable deadlines. Include conference presentations, student theses and public demonstrations in the conversation where relevant.
Protecting patent opportunities and preserving academic openness need not be opposing goals. They do require advance coordination. A promise made casually by one researcher should not be treated as an institutional confidentiality agreement.
Check international participation early
An international founder, an overseas parent company and a foreign researcher are not the same issue. Ownership review, participation eligibility, site access, export controls and manufacturing obligations can each affect a project. A company incorporated in the United States should not assume that incorporation alone resolves them.
NETL's simplified CRADA process, for example, is limited to U.S. participants and a total project value of no more than $2 million, including both parties' cash and in-kind contributions. Its partnership guidance also requires acceptance of the short form without modifications. Those conditions define that particular route, not the eligibility rules of every federal laboratory.
The Bureau of Industry and Security's deemed-export guidance explains that releasing controlled technology to a foreign person within the United States can create export-licensing obligations. It also identifies exemptions and the treatment of fundamental research. This does not mean every international collaboration needs an export license. It means the actual technology, recipient, activity and applicable rules must be assessed.
Ask the institution's export-control and security staff before sharing restricted technical material, granting remote access or arranging travel. Fundamental research treatment does not automatically settle every question about equipment, controlled inputs or site access. NETL's 2026 model, for example, addresses foreign-national access to information and technology even when work occurs away from the laboratory, and its annex specifies advance access procedures.
Commercial plans matter too. NIST's CRADA guidance says products resulting from CRADA-developed intellectual property must be substantially manufactured in the United States. If the business model depends on overseas production, raise that issue before committing to a project. Obtain advice on the actual agreement and any applicable approval process rather than assuming an exception will be granted.
Plan the work after the research
Successful research can establish a useful result while leaving substantial development ahead. A working sample may still need repeatable production, independent validation, a supply chain, customer trials and a realistic price.
A license should fit that next stage. NETL's licensing guidance describes commercialization planning and terms that can include an execution fee, minimum royalties, royalties on sales and sublicensing royalties. Exclusivity and field of use are also part of the arrangement. A company should understand which obligations begin before revenue and which depend on later activity.
Return to the imagined insulated container. If the research identifies a better coating, the team should still ask whether it can apply that coating consistently, clean it safely and produce the container at a price customers will pay. If the coating depends on licensed technology, the production and sales plan must respect that license. If the findings show the approach is unsuitable, stopping may be the most valuable outcome.
ORNL reports more than 270 collaborative projects at its Manufacturing Demonstration Facility since 2012. That is evidence of sustained partnership activity. It is not a success rate, a measure of what one participant earned or proof that this route will suit another business. Published examples and activity counts are useful starting points for questions, not substitutes for diligence.
Make the first commitment small enough to learn from
Before signing, the company and institution should be able to explain the project in ordinary language: the question, the work each side will perform, the resources committed, the deliverables, the rights needed afterward and the conditions for stopping or changing direction.
Give the first stage a decision it can genuinely support. Perhaps the result will justify a larger study. Perhaps it will identify a manufacturing weakness. Perhaps it will show that a licensing opportunity deserves further evaluation. Research should be allowed to change the plan.
A good partnership does not remove uncertainty by reputation. It gives uncertainty a competent place to be examined, with clear responsibilities and a plausible route from evidence to use. That can be a meaningful advantage for a small enterprise, provided the enterprise remains responsible for the business it intends to build.
This article provides general educational information. Institutional policies and agreement terms can change, and a specific project may need legal, intellectual-property and export-control advice.
To explore a possible collaboration with Feel Worldwide Foundation Inc. around entrepreneurship education or responsible research-to-market learning, use our partnership inquiry form. An inquiry does not secure laboratory access, funding or a commercial license. If you would like to support the Foundation's mission, you can make a donation.
